Tang Kevin
SEC Form 4 history for the last 180 days across 1 company, 14 transactions and 6 filings.
Period: Last 180 days
Trade dates in this period: Aug 26, 2026 – Nov 10, 2026
Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.
Latest insider transactions
Form 4 filings from the last 180 days.| Company | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $598View disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $4.08kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $20.1kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $1.24kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $5.41kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $25.7kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $22.9kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $14.8kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $13.9kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $521View disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $42.6kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $29.9kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% BuyForm 4 code P. Open-market or private purchase of a non-derivative or derivative security. | $277kView disclosure → | |
BOLDBoundless Bio, Inc. | 10% owner10% SellForm 4 code S. Open-market or private sale of a non-derivative or derivative security. | −$54.4kView disclosure → |
Latest Form 4 facts
Quick context from source filings
The insider reported a buy at Boundless Bio, Inc. on Nov 10, 2026 valued at $597.60.
Review SEC filingThe insider reported a sale at Boundless Bio, Inc. on Aug 26, 2026 valued at $54,351.
Review SEC filingMonthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 0 | 1 | $0 | $54,351 | −$54,351 |
| Oct 2026 | 8 | 0 | $426,908.97 | $0 | +$426,908.97 |
| Nov 2026 | 5 | 0 | $31,466.40 | $0 | +$31,466.40 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Counts cover all available history, including outside the summary period
Open-market buy performance
90-day forward return on this insider's open-market purchases
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
14 observations · Aug 26, 2026 – Nov 10, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 26, 2026 | 2,840,635 | Aug 28, 2026 | View transaction |
| Oct 16, 2026 | 2,958,820 | Oct 20, 2026 | View transaction |
| Oct 19, 2026 | 2,971,610 | Oct 20, 2026 | View transaction |
| Oct 19, 2026 | 2,989,889 | Oct 20, 2026 | View transaction |
| Oct 20, 2026 | 2,990,109 | Oct 20, 2026 | View transaction |
| Oct 22, 2026 | 2,995,909 | Oct 26, 2026 | View transaction |
| Oct 23, 2026 | 3,002,143 | Oct 26, 2026 | View transaction |
| Oct 26, 2026 | 3,011,749 | Oct 26, 2026 | View transaction |
| Oct 27, 2026 | 3,022,456 | Oct 29, 2026 | View transaction |
| Nov 3, 2026 | 3,024,711 | Nov 5, 2026 | View transaction |
| Nov 4, 2026 | 3,025,228 | Nov 5, 2026 | View transaction |
| Nov 5, 2026 | 3,033,618 | Nov 5, 2026 | View transaction |
| Nov 6, 2026 | 3,035,318 | Nov 10, 2026 | View transaction |
| Nov 10, 2026 | 3,035,567 | Nov 10, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Tang Kevin Insider Activity FAQ
SEC Form 4 context
Who is Tang Kevin?
Tang Kevin is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001178579.
Which companies has Tang Kevin reported transactions for?
Boundless Bio, Inc., Aurinia Pharmaceuticals Inc., Singular Genomics Systems, Inc.
When was Tang Kevin's latest insider buy?
The insider reported a buy at Boundless Bio, Inc. on Nov 10, 2026 valued at $597.60.
When was Tang Kevin's latest insider sale?
The insider reported a sale at Boundless Bio, Inc. on Aug 26, 2026 valued at $54,351.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.